I studiet med de 204 patienter, som fik Zevalin- konsolideringsbehandling efter remissionsinduktion med 1. linjebehandling, forekom der infektioner hyppigere end angivet i tabellen ovenfor (meget almindeligt).
In the study with 204 patients receiving Zevalin as consolidation following first-line remission induction, infections were observed more frequently than as described in the above table (very common).